ChemoMetec A/S (CHY) Stock Statistics & Valuation Metrics

ChemoMetec A/S has a market cap or net worth of €1.21B. The enterprise value is €6.01K.

ChemoMetec A/S has 17,402,480 shares outstanding. The number of shares has decreased by -2.65% in one year.

ChemoMetec A/S’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 26.69%.

The current PE Ratio of ChemoMetec A/S is 44.0. ChemoMetec A/S’s PEG ratio is ―.

In the last 12 months, ChemoMetec A/S had revenue of 511.06M and earned 201.84M in profits. Earnings per share was 11.60.

In the last 12 months, operating cash flow was 210.36M and capital expenditures -28.31M, giving a free cash flow of 182.04M billion.

ChemoMetec A/S pays an annual dividend of ―, resulting in a dividend yield of ―

ChemoMetec A/S upcoming earnings date is Feb 3, 2027, TBA (Not Confirmed).

ChemoMetec A/S as a current ratio of 4.09, with Debt / Equity ratio of 0.63%

In the past 12 months, ChemoMetec A/S has paid 56.34M in taxes.

ChemoMetec A/S EV to EBITDA ratio is 21.39, with an EV/FCF ratio of 33.05.

ChemoMetec A/S has €293.56M in cash and marketable securities with €7.78M in debt, giving a net cash position of €288.97M billion.

Gross margin is 64.30%, with operating margin of 49.11%, and net profit margin of 39.49%.

The average price target for ChemoMetec A/S is €66.89, which is 11.43% higher than the current price. The consensus rating is Hold